Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00322_DB00682_nanopub.RA4TYYLPHKThpMIojtZtwHCqOW5SGC8yADs7U6SM9b-RA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00322_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00322_DB00682 label "DDI between Floxuridine and Warfarin - Floxuridine, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if floxuridine is initiated, discontinued or dose changed. [drugbank_resource:DB00322_DB00682]" assertion.
- drugbank_resource:DB00322_DB00682 identifier "drugbank_resource:DB00322_DB00682" assertion.
- drugbank_resource:DB00322_DB00682 title "DDI between Floxuridine and Warfarin - Floxuridine, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if floxuridine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00322_DB00682 assertion.
- drugbank:DB00322 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00322_DB00682 assertion.